Liu et al., 2018 - Google Patents
Potential effect of mechano growth factor E‐domain peptide on axonal guidance growth in primary cultured cortical neurons of ratsLiu et al., 2018
- Document ID
- 9981755637113051228
- Author
- Liu M
- Niu X
- Zhou G
- Jia Z
- Li P
- Fan Y
- Publication year
- Publication venue
- Journal of Tissue Engineering and Regenerative Medicine
External Links
Snippet
Establishing appropriate synaptic connections and plasticity is a critical need in neuronal regeneration and development. Mechano growth factor (MGF) and its C‐terminal E‐domain peptide with 24 amino acids, MGF‐Ct24E, are potential neuroprotective agents. Our …
- 230000003376 axonal 0 title abstract description 55
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/711—Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Zhou et al. | Myofiber necroptosis promotes muscle stem cell proliferation via releasing Tenascin-C during regeneration | |
Su et al. | Overexpression of P2X4 receptor in Schwann cells promotes motor and sensory functional recovery and remyelination via BDNF secretion after nerve injury | |
Formicola et al. | Neuronal ribonucleoprotein granules: Dynamic sensors of localized signals | |
Rossi et al. | Nfix regulates temporal progression of muscle regeneration through modulation of myostatin expression | |
Jiménez-Loygorri et al. | Mitophagy curtails cytosolic mtDNA-dependent activation of cGAS/STING inflammation during aging | |
De Bock et al. | Connexin channels provide a target to manipulate brain endothelial calcium dynamics and blood—brain barrier permeability | |
Cox et al. | Intra-axonal translation and retrograde trafficking of CREB promotes neuronal survival | |
Mircsof et al. | Mutations in NONO lead to syndromic intellectual disability and inhibitory synaptic defects | |
Egerman et al. | The role of GDF11 in aging and skeletal muscle, cardiac and bone homeostasis | |
Tseng et al. | Induction of vertebrate regeneration by a transient sodium current | |
Ge et al. | Smad3 signaling is required for satellite cell function and myogenic differentiation of myoblasts | |
Ji et al. | Intra-axonal translation of SMAD1/5/8 mediates retrograde regulation of trigeminal ganglia subtype specification | |
Smith et al. | GAP‐43 mRNA in growth cones is associated with HuD and ribosomes | |
Dupraz et al. | The insulin-like growth factor 1 receptor is essential for axonal regeneration in adult central nervous system neurons | |
Pernet et al. | Neuronal Nogo-A upregulation does not contribute to ER stress-associated apoptosis but participates in the regenerative response in the axotomized adult retina | |
Luan et al. | SUMOylation of Pax7 is essential for neural crest and muscle development | |
Meng et al. | Toll-like receptor-4/p38 MAPK signaling in the dorsal horn contributes to P2X4 receptor activation and BDNF over-secretion in cancer induced bone pain | |
Gladwyn-Ng et al. | Bacurd1/Kctd13 and Bacurd2/Tnfaip1 are interacting partners to Rnd proteins which influence the long-term positioning and dendritic maturation of cerebral cortical neurons | |
Liu et al. | Potential effect of mechano growth factor E‐domain peptide on axonal guidance growth in primary cultured cortical neurons of rats | |
Nadjar et al. | The Susd2 protein regulates neurite growth and excitatory synaptic density in hippocampal cultures | |
Vilallongue et al. | Guidance landscapes unveiled by quantitative proteomics to control reinnervation in adult visual system | |
Meares et al. | HSP105 interacts with GRP78 and GSK3 and promotes ER stress-induced caspase-3 activation | |
He et al. | A critical role for Γcamkii in decoding nmda signaling to regulate ampa receptors in putative inhibitory interneurons | |
Li et al. | Krüppel-like factor 7 attenuates hippocampal neuronal injury after traumatic brain injury | |
Takayama et al. | Involvement of ERCC1 in the pathogenesis of osteoarthritis through the modulation of apoptosis and cellular senescence |